Short‐course versus long‐course intravenous therapy with the same antibiotic for severe community‐acquired pneumonia in children aged two months to 59 months
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Short‐course Versus Long‐course Intravenous Therapy With the Same Antibiotic for Severe Community‐acquired Pneumonia in Children Aged Two Months to 59 Months." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/433038/all/images/ios-appstore-badge.png. Accessed 16 May 2024.
Short‐course versus long‐course intravenous therapy with the same antibiotic for severe community‐acquired pneumonia in children aged two months to 59 months. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/433038/all/images/ios-appstore-badge.png. Accessed May 16, 2024.
Short‐course versus long‐course intravenous therapy with the same antibiotic for severe community‐acquired pneumonia in children aged two months to 59 months. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/433038/all/images/ios-appstore-badge.png
Short‐course Versus Long‐course Intravenous Therapy With the Same Antibiotic for Severe Community‐acquired Pneumonia in Children Aged Two Months to 59 Months [Internet]. In: Cochrane Abstracts. [cited 2024 May 16]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/433038/all/images/ios-appstore-badge.png.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Short‐course versus long‐course intravenous therapy with the same antibiotic for severe community‐acquired pneumonia in children aged two months to 59 months
ID - 433038
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/433038/all/images/ios-appstore-badge.png
DB - Evidence Central
DP - Unbound Medicine
ER -